Cigna shares tumble as Q4 earnings miss, 2025 outlook disappoints
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Raymond James Reiterates Strong Buy Rating on CIGNA (CI)
January 30, 2025 8:44 AM ESTRaymond James analyst John Ransom reiterated a Strong Buy rating and $415.00 price target on CIGNA (NYSE: CI)
The analyst comments "Event: This morning, Cigna reported 4Q24 results that significantly missed expectations, with adj. revenue of $65.7B (Street: $63.1B; RJ: $64.9B), adj. EBT of $2.23B (Street $2.78B; RJ: $2.84B), and adj. EPS of $6.64 (Street: $7.82; RJ: $7.78), while MLR came in at 87.9% (Street: 84.7%, RJ: 84.9%). At first glance, the main highlight of the... More
BofA on CIGNA (CI): 'Quarter and outlook disappoint, valuation pressured'
January 30, 2025 8:37 AM ESTBofA Securities analyst Adam Ron reiterated a Buy rating and $420.00 price target on CIGNA (NYSE: CI).
The analyst comments "CI unexpectantly missed 4Q earnings by 13% in the quarter ($1.03), and lowered its view of 2025 by $1.74 (6%). With the new outlook, the company is now... More
